Dr. Elran Haber, CEO of Biomica, will be available for one-on-one meetings throughout the week, starting on Monday, January 8, and concluding on Thursday, January 11, 2024.
Biomica Ltd. has announced the opening of a second site at The Davidoff Cancer Center for its ongoing Phase
Biomica Ltd. has announced the opening of a second site at The Davidoff Cancer Center for its ongoing Phase
The pre-clinical work was performed in collaboration with the lab of Prof. Kara Gross Margolis, Associate Director for Clinical and Translational Research for the New York University Pain Research Center and an Associate Professor in the Department of Molecular Pathobiology in the NYU College of Dentistry and the Department of Pediatrics at NYU Grossman School of Medicine.
Our VP R&D, Dr. Shiri Meshner, will be presenting at the Pharmabiotics 2023 Conference, “The Future of Microbiome-based Medicines”, taking place in Lyon, France from March 21-22, 2023.
